synergychc.com - SNYR Total Enterprise Value

Brandmark of synergychc.com (SNYR)

Synergy CHC Corp (SNYR) is a consumer conglomerate with a powerful brand image in the beauty and wellness segment, where customer trust is built on the purity of product ingredients. Market entry is restricted by strict hygiene regulations and retail privileges. This price trend reflects an Enterprise Value of 28.74, while business development requires colossal advertising expenditures due to the accessibility of online sales for competitors.

SNYR - Synergy CHC Corp. Total Company Value over the range 11/23/2025 - 10/03/2026
Brand item of Synergy CHC

Enterprise value combines market capitalization and net debt, reflecting the actual price for a full buyout of the business. For Synergy CHC Corp (SNYR), with its asset-light model, this parameter demonstrates scaling efficiency via its IT platform without excessive expenditures on factories. The dynamics of the enterprise value indicator allow for the real-time assessment of asset value. Analysis of this chart helps identify the company's undervaluation relative to its operating leverage, which is critical for an objective fundamental evaluation of the holding's investment attractiveness.

Competitors of Synergy CHC Corp (SNYR)

HLN: Business Value|KVUE: Real Price to Acquire Entire Company|Total Enterprise Value Verona Pharma Inc.|Jyong Biotech Ltd (MENS) - Total Company Value|ligand.com - Value Adjusted for Debt and Cash|Total Company Value Amneal|Perrigo Company PLC - Full Business Value|Enterprise Value ALVO|LQDA (Liquidia Inc.) - Value Adjusted for Debt and Cash|Enterprise Value GLPG (Galapagos NV)|Enterprise Value anipharmaceuticals.com ANIP|MNKD - Total Company Value|Value Adjusted for Debt and Cash AMPH (Amphastar Pharmaceuticals Inc)|Pacira (PCRX) - Total Company Value|Real Price to Acquire Entire Company ARS Corp|TBPH (Theravance Biopharma) - Enterprise Value|Enterprise Value aquestive.com|Real Price to Acquire Entire Company SCPH (scPharmaceuticals Inc.)|TECX (tectonictx.com) - Value Adjusted for Debt and Cash|Total Company Value Tonix Pharmaceuticals Inc. TNXP|SXT Pharmaceuticals (SXTC) - Total Enterprise Value|EPRX: Real Price to Acquire Entire Company|bioharvest.com - Aggregate Business Value|EXOZ: Enterprise Value|Oramed Pharmaceuticals Inc. - Value Adjusted for Debt and Cash|ENTX (Entera Bio Ltd) - Enterprise Value|Total Enterprise Value MindWalk Therapeutics HYFT|Total Company Value ABVC BioPharma (ABVC)|CPIX (cumberlandpharma.com) - Value Adjusted for Debt and Cash|Total Company Value Quantum BioPharma QNTM|Company Buyout Price FibroGen Inc (FGEN)|TELO: Real Price to Acquire Entire Company|Total Enterprise Value Rani Therapeutics|rallybio.com (RLYB) - Total Company Value|Business Value LEXX|PULM (Pulmatrix) - Enterprise Value|Total Enterprise Value Pheton PTHL|Total Company Value Aptorum Group Limited (APM)|LYRA (Lyra Therapeutics Inc) - Value Adjusted for Debt and Cash|Enterprise Value IBO (Impact BioMedical)|Full Takeover Company Value TNF Pharmaceuticals Inc.|YCBD: Real Price to Acquire Entire Company|Total Enterprise Value PainReform Ltd|CYTO (altamiratherapeutics.com) - Real Price to Acquire Entire Company|Lipella Pharma - Value Adjusted for Debt and Cash|OPTN (OptiNose, Inc.) - Enterprise Value|Real Price to Acquire Entire Company pieris.com (PIRS)|Enterprise Value PROC|PTPI (Petros Pharmaceuticals Inc) - Value Adjusted for Debt and Cash|Enterprise Value QLI (Qilian International Holding Group Limited)|SLRN - Real Price to Acquire Entire Company|TFFP: Real Price to Acquire Entire Company